Herrero M, Moreno F
J Gen Microbiol. 1986 Feb;132(2):393-402. doi: 10.1099/00221287-132-2-393.
Microcin B17 is a novel peptide antibiotic of low Mr (about 4000) produced by Escherichia coli strains carrying plasmid pMccB17. The action of this microcin in sensitive cells is essentially irreversible, follows single-hit kinetics, and leads to an abrupt arrest of DNA replication and, consequently, to the induction of the SOS response. RecA- and RecBC- strains are hypersensitive to microcin B17. Strains producing a non-cleavable SOS repressor (lexAl mutant) are also more sensitive than wild-type, whereas strains carrying a mutation which causes constitutive expression of the SOS response (spr-55) are less sensitive to microcin. Microcin B17 does not induce the SOS response in cells which do not have an active replication fork. The results suggest that the mode of action of this microcin is different from all other well-characterized microcins and colicins, and from other antibiotics which inhibit DNA replication.
微菌素B17是一种由携带质粒pMccB17的大肠杆菌菌株产生的新型低分子量(约4000)肽抗生素。这种微菌素在敏感细胞中的作用基本上是不可逆的,遵循单次打击动力学,并导致DNA复制突然停止,进而诱导SOS反应。RecA和RecBC缺陷型菌株对微菌素B17高度敏感。产生不可裂解的SOS阻遏物的菌株(lexAl突变体)也比野生型更敏感,而携带导致SOS反应组成型表达的突变的菌株(spr-55)对微菌素不太敏感。微菌素B17在没有活跃复制叉的细胞中不会诱导SOS反应。结果表明,这种微菌素的作用方式不同于所有其他已充分表征的微菌素和大肠杆菌素,也不同于其他抑制DNA复制的抗生素。